DailyStocks Stock Article Search

https://www.zacks.com/stock/news/2250508/biotricity-btcy-may-find-a-bottom-soon-here-s-why-you-should-buy-the-stock-now?cid=CS-ZC-FT-tale_of_the_tape|hammer_chart_pattern_(ta)-2250508 Apr 04, 2024 - After losing some value lately, a hammer chart pattern has been formed for Biotricity (BTCY), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term. 0

https://www.zacks.com/stock/news/2250507/monopar-therapeutics-mnpr-could-find-a-support-soon-here-s-why-you-should-buy-the-stock-now?cid=CS-ZC-FT-tale_of_the_tape|hammer_chart_pattern_(ta)-2250507 Apr 04, 2024 - Monopar Therapeutics (MNPR) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term. 0

https://www.zacks.com/stock/news/2250509/here-s-why-carisma-therap-carm-is-a-great-buy-the-bottom-stock-now?cid=CS-ZC-FT-tale_of_the_tape|hammer_chart_pattern_(ta)-2250509 Apr 04, 2024 - CARISMA THERAP (CARM) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term. 0

https://www.zacks.com/stock/news/2250445/are-investors-undervaluing-vontier-vnt-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_2-2250445 Apr 04, 2024 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. 0

https://www.zacks.com/stock/news/2250446/are-investors-undervaluing-jd-com-jd-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_2-2250446 Apr 04, 2024 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. 0

https://www.zacks.com/stock/news/2250294/why-investors-need-to-take-advantage-of-these-2-computer-and-technology-stocks-now?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_earnings_esp-2250294 Apr 04, 2024 - The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now. 0

https://www.zacks.com/stock/news/2250299/why-investors-need-to-take-advantage-of-these-2-medical-stocks-now?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_earnings_esp-2250299 Apr 04, 2024 - Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP. 0

https://seekingalpha.com/article/4681969-2-fat-dividends-i-am-buying-now?source=feed Apr 04, 2024 - Inflation has reduced the purchasing power of even a six-figure income, making it harder to maintain a comfortable retirement. Click here for 2 lifelong income providers. 0

https://www.wired.com/story/p4x-north-korea-internet-hacker-identity-reveal/ Apr 04, 2024 - As “P4x,” Alejandro Caceres single-handedly disrupted the internet of an entire country. Then he tried to show the US military how it can—and should—adopt his methods. 0

https://seekingalpha.com/article/4682065-novartis-stock-higher-guidance-now-buy-rating-upgrade?source=feed_all_articles Apr 03, 2024 - Novartis reported solid 2023 financial results and increased its dividend per share. Click here to see why NVS stock is a Buy. 0